Patient selection for liver transplantation

References

• Murray KF, Carithers RL Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 41(6), 1407–1432 (2005).
   PubMed Web of Science ®Google Scholar
• Lang H, Sotiropoulos GC, Domland M et al. Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br. J. Surg. 92(2), 198–202 (2005).
   PubMed Web of Science ®Google Scholar
• Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J. Am. Coll. Surg. 191(1), 38–46 (2000).
   PubMedGoogle Scholar
• European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 56(4), 908–943 (2012).
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 53(3), 1020–1022 (2011).
   PubMed Web of Science ®Google Scholar
• Chua TC, Saxena A, Chu F, Morris DL. Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria. Am. J. Clin. Oncol. 35(2), 141–145 (2012).
   PubMedGoogle Scholar
• Hu Z, Zhou J, Xu X et al. Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection. PloS ONE 7(5), e36587 (2012).
   PubMedGoogle Scholar
• Hu Z, Wang W, Li Z, Ye S, Zheng SS. Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis. Liver Transplant. 18(11), 1316–1323 (2012).
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334(11), 693–699 (1996).
   PubMed Web of Science ®Google Scholar
• Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33(6), 1394–1403 (2001).
   PubMed Web of Science ®Google Scholar
• Park SJ, Freise CE, Hirose R et al. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin. Transplant. 26(4), e359–e364 (2012).
   PubMedGoogle Scholar
• Goldberg D, French B, Abt P, Feng S, Cameron AM. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transplant. 18(4), 434–443 (2012).
   PubMedGoogle Scholar
• Heckman JT, Devera MB, Marsh JW et al. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann. Surg. Oncol. 15(11), 3169–3177 (2008).
   PubMed Web of Science ®Google Scholar
• Peng ZW, Zhang YJ, Chen MS et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J. Clin. Oncol. 31(4), 426–432 (2013).
   PubMed Web of Science ®Google Scholar
• Cheng BQ, Jia CQ, Liu CT et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299(14), 1669–1677 (2008).
   PubMed Web of Science ®Google Scholar
• Yu CY, Ou HY, Huang TL et al. Hepatocellular carcinoma downstaging in liver transplantation. Transplant. Proc. 44(2), 412–414 (2012).
   PubMed Web of Science ®Google Scholar
• Friman S. Cholangiocarcinoma – current treatment options. Scand. J. Surg. 100(1), 30–34 (2011).
   PubMed Web of Science ®Google Scholar
• Rea DJ, Heimbach JK, Rosen CB et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann. Surg. 242(3), 451–458; discussion 458–461 (2005).
   PubMed Web of Science ®Google Scholar
• Darwish Murad S, Kim WR, Harnois DM et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 143(1), 88.e3–98.e3; quiz e14 (2012).
   Google Scholar
• Faraj W, Dar F, Marangoni G et al. Liver transplantation for hepatoblastoma. Liver Transplant. 14(11), 1614–1619 (2008).
   PubMed Web of Science ®Google Scholar
• Browne M, Sher D, Grant D et al. Survival after liver transplantation for hepatoblastoma: a 2-center experience. J. Pediatr. Surg. 43(11), 1973–1981 (2008).
   PubMedGoogle Scholar
• Srinivasan P, Mccall J, Pritchard J et al. Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation 74(5), 652–655 (2002).
   PubMedGoogle Scholar
• Czauderna P, Otte JB, Aronson DC et al. Guidelines for surgical treatment of hepatoblastoma in the modern era – recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur. J. Cancer 41(7), 1031–1036 (2005).
   PubMedGoogle Scholar
• Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 55(3), 965–967 (2012).
   PubMed Web of Science ®Google Scholar
• Tiukinhoy-Laing SD, Rossi JS, Bayram M et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am. J. Cardiol. 98(2), 178–181 (2006).
   PubMed Web of Science ®Google Scholar
• Lentine KL, Costa SP, Weir MR et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J. Am. Coll. Cardiol. 60(5), 434–480 (2012).
   PubMedGoogle Scholar
• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8(5), 1151–1157 (1988).
   PubMed Web of Science ®Google Scholar
• Krowka MJ. Management of pulmonary complications in pretransplant patients. Clin. Liver Dis. 15(4), 765–777 (2011).
   PubMedGoogle Scholar
• Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment. Pharmacol. Ther. 20(3), 271–279 (2004).
   PubMed Web of Science ®Google Scholar
• Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J. Thorac. Cardiovasc. Surg. 130(1), 141–145 (2005).
   PubMed Web of Science ®Google Scholar
• Dhanasekaran R, West JK, Gonzales PC et al. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am. J. Gastroenterol. 105(3), 635–641 (2010).
   PubMed Web of Science ®Google Scholar
• Serste T, Moreno C, Francoz C et al. The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation. Eur. J. Gastroenterol. Hepatol. 22(2), 207–212 (2010).
   PubMed Web of Science ®Google Scholar
• Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin. Gastroenterol. Hepatol. 5(6), 749–754 (2007).
   PubMedGoogle Scholar
• Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome – a liver-induced lung vascular disorder. N. Engl. J. Med. 358(22), 2378–2387 (2008).
   PubMed Web of Science ®Google Scholar
• Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125(4), 1042–1052 (2003).
   PubMed Web of Science ®Google Scholar
• Swanson KL. Should we screen for hepatopulmonary syndrome in liver transplant candidates? Liver Transplant. 13(2), 183–184 (2007).
   PubMedGoogle Scholar
• Ahmed A, Keeffe EB. Current indications and contraindications for liver transplantation. Clin. Liver Dis. 11(2), 227–247 (2007).
   PubMedGoogle Scholar
• Grewal P, Martin P. Pretransplant management of the cirrhotic patient. Clin. Liver Dis. 11(2), 431–449 (2007).
   PubMedGoogle Scholar
• Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig. Dis. Sci. 50(12), 2338–2343 (2005).
   PubMed Web of Science ®Google Scholar
• Savransky V, Nanayakkara A, Vivero A et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45(4), 1007–1013 (2007).
   PubMed Web of Science ®Google Scholar
• Polotsky VY, Patil SP, Savransky V et al. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am. J. Respir. Crit. Care Med. 179(3), 228–234 (2009).
   PubMedGoogle Scholar
• Roland ME, Stock PG. Liver transplantation in HIV-infected recipients. Sem. Liver Dis. 26(3), 273–284 (2006).
   PubMed Web of Science ®Google Scholar
• Terrault NA, Roland ME, Schiano T et al. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transplant. 18(6), 716–726 (2012).
   PubMed Web of Science ®Google Scholar
• Samuel D, Muller R, Alexander G et al. Liver transplantation in European patients with the hepatitis B surface antigen. N. Engl. J. Med. 329(25), 1842–1847 (1993).
   PubMed Web of Science ®Google Scholar
• O’grady JG, Smith HM, Davies SE et al. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J. Hepatol. 14(1), 104–111 (1992).
   PubMed Web of Science ®Google Scholar
• Schiff E, Lai CL, Hadziyannis S et al. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results. Liver Transplant. 13(3), 349–360 (2007).
   PubMed Web of Science ®Google Scholar
• Tan HH, Martin P. Care of the liver transplant candidate. Clin. Liver Dis. 15(4), 779–806 (2011).
   PubMedGoogle Scholar
• European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J. Hepatol. 55(2), 245–264 (2011).
   PubMed Web of Science ®Google Scholar
• Iacobellis A, Siciliano M, Perri F et al. Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study. J. Hepatol. 46(2), 206–212 (2007).
   PubMed Web of Science ®Google Scholar
• Everson GT, Trotter J, Forman L et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 42(2), 255–262 (2005).
   PubMed Web of Science ®Google Scholar
• Kalia H, Fabrizi F, Martin P. Hepatitis B virus and renal transplantation. Transplant. Rev. (Orlando) 25(3), 102–109 (2011).
   PubMedGoogle Scholar
• Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am. J. Transplant. 8(1), 9–14 (2008).
   PubMed Web of Science ®Google Scholar
• Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology 48(6), 2064–2077 (2008).
   PubMed Web of Science ®Google Scholar
• Fede G, D’amico G, Arvaniti V et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J. Hepatol. 56(4), 810–818 (2012).
   PubMed Web of Science ®Google Scholar
• Arroyo V, Gines P, Gerbes AL et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23(1), 164–176 (1996).
   PubMed Web of Science ®Google Scholar
• Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56(9), 1310–1318 (2007).
   PubMed Web of Science ®Google Scholar
• Restuccia T, Ortega R, Guevara M et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case–control study. J. Hepatol. 40(1), 140–146 (2004).
   PubMed Web of Science ®Google Scholar
• Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35(5), 1179–1185 (2002).
   PubMed Web of Science ®Google Scholar
• Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD. Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am. J. Transplant. 8(11), 2243–2251 (2008).
   PubMed Web of Science ®Google Scholar
• Kaemmerer D, Benjamin S, Gabriele L, Gunter W, Utz S, Merten H. Treatment of bone loss in patients with chronic liver disease awaiting liver transplantation. Transplant. Res. 1(1), 7 (2012).
   PubMedGoogle Scholar
• Iasi MS, Vieira A, Anez CI et al. Recurrence of alcohol ingestion in liver transplantation candidates. Transplant. Proc. 35(3), 1123–1124 (2003).
   PubMedGoogle Scholar
• Lucey MR, Brown KA, Everson GT et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transplant. Surg. 3(6), 628–637 (1997).
   PubMedGoogle Scholar
• Mathurin P, Moreno C, Samuel D et al. Early liver transplantation for severe alcoholic hepatitis. N. Engl. J. Med. 365(19), 1790–1800 (2011).
   PubMed Web of Science ®Google Scholar
• Dimartini A, Day N, Dew MA et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transplant. 12(5), 813–820 (2006).
   PubMed Web of Science ®Google Scholar
• Pungpapong S, Manzarbeitia C, Ortiz J et al. Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transplant. 8(7), 582–587 (2002).
   PubMed Web of Science ®Google Scholar
• Dimartini A, Crone C, Dew MA. Alcohol and substance use in liver transplant patients. Clinics in liver disease 15(4), 727–751 (2011).
   PubMed Web of Science ®Google Scholar
• Dick AA, Spitzer AL, Seifert CF et al. Liver transplantation at the extremes of the body mass index. Liver Transplant. 15(8), 968–977 (2009).
   PubMedGoogle Scholar
• Dicecco SR, Wieners EJ, Wiesner RH, Southorn PA, Plevak DJ, Krom RA. Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin. Proc. 64(1), 95–102 (1989).
   PubMed Web of Science ®Google Scholar
• Merli M, Lucidi C, Giannelli V et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin. Gastroenterol. Hepatol. 8(11), 979–985 (2010).
   PubMed Web of Science ®Google Scholar
• Sam J, Nguyen GC. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver Int. 29(9), 1396–1402 (2009).
   PubMed Web of Science ®Google Scholar
• Kachaamy T, Bajaj JS. Diet and cognition in chronic liver disease. Curr. Opin. Gastroenterol. 27(2), 174–179 (2011).
   PubMedGoogle Scholar
• Gunsar F, Raimondo ML, Jones S et al. Nutritional status and prognosis in cirrhotic patients. Aliment. Pharmacol. Ther. 24(4), 563–572 (2006).
   PubMedGoogle Scholar
• Ferreira LG, Anastacio LR, Lima AS, Correia MI. Assessment of nutritional status of patients waiting for liver transplantation. Clin. Transplant. 25(2), 248–254 (2011).
   PubMedGoogle Scholar
• Merli M, Giusto M, Gentili F et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int. 30(2), 208–214 (2010).
   PubMed Web of Science ®Google Scholar
• Dobbels F, Vanhaecke J, Dupont L et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 87(10), 1497–1504 (2009).
   PubMed Web of Science ®Google Scholar
• Lieber SR, Volk ML. Non-adherence and graft failure in adult liver transplant recipients. Dig. Dis. Sci. 58(3), 824–834 (2012).
   PubMedGoogle Scholar
• Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4), 864–871 (2000).
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33(2), 464–470 (2001).
   PubMed Web of Science ®Google Scholar
• Neff GW, O’brien C, Montalbano M et al. Consumption of dietary supplements in a liver transplant population. Liver Transplant. 10(7), 881–885 (2004).
   PubMedGoogle Scholar
• Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am. J. Transplant. 5(2), 307–313 (2005).
   PubMed Web of Science ®Google Scholar
• Habib S, Berk B, Chang CC et al. MELD and prediction of post-liver transplantation survival. Liver Transplant. 12(3), 440–447 (2006).
   PubMed Web of Science ®Google Scholar
• Suzuki H, Bartlett AS, Muiesan P, Jassem W, Rela M, Heaton N. High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation. Transplant. Proc. 44(2), 384–388 (2012).
   PubMedGoogle Scholar
• Brown RS Jr, Russo MW, Lai M et al. A survey of liver transplantation from living adult donors in the United States. N. Engl. J. Med. 348(9), 818–825 (2003).
   PubMedGoogle Scholar